OrthoLazer
Greg Barnett is a seasoned executive in the fields of sales and marketing with extensive experience in the healthcare and technology sectors. Currently serving as Chief Growth Officer at OrthoLazer Orthopedic Laser Centers since 2019, Barnett focuses on expanding franchise opportunities that provide opioid-free pain management solutions. Prior to this role, Barnett held the position of Vice President of Sales and Marketing at Cutting Edge Lasers, Inc., achieving a remarkable 143% revenue increase. As an Independent Consultant from 2006 to 2011, Barnett worked with high-profile clients including HP, NetApp, and LinkedIn. Barnett co-founded Lightyear Technologies, scaling the company to a $25M run rate in six years, and also co-founded DEXIS, leading it to $15M in revenue before its acquisition by Danaher. Barnett holds a Bachelor of Science degree in Physiology from Slippery Rock University of Pennsylvania.
This person is not in any teams
This person is not in any offices
OrthoLazer
OrthoLazer Orthopedic Laser Centers offer both patients and their orthopedic doctors an innovative and effective alternative pain management option to treat acute and chronic orthopedic conditions. Founded by Dr. Scott Sigman – the original opioid-sparing surgeon – these centers further his mission of providing his patients non-operative and non-opioid treatment options. The overwhelming patient response to his first OrthoLazer Center led to the new initiative to make OrthoLazer Centers available to patients nationwide. OrthoLazer Orthopedic Laser Centers are powered by the exclusive MLS M8 Robotic Laser. This FDA-cleared and patented technology treats the pain and inflammation associated with a wide variety of soft tissue injuries, nerve pain, arthritis and surgery with no known side effects. Additionally, the MLS M8 Robotic Laser is the only high-powered laser that is non-invasive, painless, and completely free of the side effects and risks associated with other lasers used in the market today.